Varian carcinomas connected with BRCA1 or BRCA2 mutations leads to elevated
Varian carcinomas linked with BRCA1 or BRCA2 mutations results in increased sensitivity to platinum-based agents and longer survival6. Preclinically, it was observed that cells lacking functional BRCA1 or BRCA2, were…